Nasir cv website
Yüklə 230,22 Kb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- C. Publications
08/04/2010
40. Automatic Atrial Defibrillation System Clinical Study a. 1997-‐1999 b. The Methodist Hospital c. Co-‐Investigator 41. Model 7250 Arrhythmia Management Device Investigational Plan a. 1996-‐present b. The Methodist Hospital c. Co-‐ Investigator 42. Clinical Investigation of Res-‐Q DR 101-‐16 a. 1998-‐1999 b. The Methodist Hospital c. Co-‐Investigator 43. A Double-‐Blind, Placebo-‐Controlled, Randomized Clinical Trial of Slow Release Propafenone (Rythmol-‐SR) in the Prevention of Symptomatic Recurrences of Atrial Fibrillation a. 1998-‐2000 b. Texas Arrhythmia Institute c. Co-‐Investigator 44. Ventak CHF AICD Biventricular Pacing Study Investigational Plan a. 1998-‐present b. The Methodist Hospital c. Co-‐Investigator 45. A Prospective, Multinational, Multicenter, Double-‐Blind, Randomized, Active-‐Controlled Trial in Patients with Essential Hypertension to Compare the Effect of Valsartan 80 and 160mg, With or Without the Addition of Hydrocholorothiazide, Once Daily to that of Amlodipine 5 and 10mg Once Daily, With or Without the Addition of Hydrochlorothiazide, on Cardiovascular Morbidity and Mortality a. 1998-‐present b. Texas Arrhythmia Institute c. Co-‐Investigator 46. Radiofrequency Ablation of Accessory Pathways, AV Nodal Reentry Tachycardia and the AV Node for Rate Control Using the Bard Ablation System (St. Jude Medical Photon DR, Model V-‐230HV) a. 1999-‐2000 b. Texas Arrhythmia Institute c. Co-‐Investigator 47. Vigor CHF Biventricular Pacing in Congestive Heart Failure a. 1999-‐2000 b. Texas Arrhythmia Institute c. Co-‐Investigator 48. Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (Companion Study) a. 2001-‐2004 b. The Methodist Hospital c. Co-‐Investigator 49. Resynchronization for Hemodynamic Treatment for Heart Failure Management (Rhythm ICD) St. Jude Medical
a. 2002-‐2004 b. The Methodist Hospital c. Co-‐Investigator 50. Resynchronization for Hemodynamic Treatment for Heart Failure Management Study (Rhythm ICD) Quicksite Left Heart Lead Model 1056K St. Jude Medical a. 2004-‐2005 b. The Methodist Hospital c. Co-‐Investigator 51. Medtronic Ensure Study a. 2004-‐2006
08/04/2010
b. The Methodist Hospital c. Principal Investigator 52. Guidant CRT-‐Renewal Registry Study a. 2004-‐2006 b. The Methodist Hospital c. Principal Investigator 53. Medtronic Trends Study a. 2004-‐2007 b. The Methodist Hospital c. Principal Investigator 54. Medtronic Reverse Study a. 2004-‐present b. The Methodist Hospital c. Principal Investigator 55. Evaluation of the AT/AF Patient Notification Feature in Patients with a Bradycardia Indication for Pacing Study a. 2005 b. The Methodist Hospital c. Co-‐Investigator 56. Resynchronization for Hemodynamic Treatment for Heart Failure Management Study (Rhythm ICD) Quicksite Left Heart Lead Model 1056T St. Jude Medical a. 2005-‐2006 b. The Methodist Hospital c. Co-‐Investigator 57. Post Approval Study (St. Jude Medical) Principal Investigator (after 11/05) a. 2005-‐present b. The Methodist Hospital c. Co-‐Investigator 58. AF Suppression/CRT-‐D Study (St. Jude Medical) Principal Investigator (after 11/05) a. 2005-‐2006 b. The Methodist Hospital c. Co-‐Investigator 59. Victory IDE Pacemaker Study (St. Jude Medical) a. 2006-‐2007 b. The Methodist Hospital c. Principal Investigator 60. Rethinq Study Resynchronization Therapy in Normal QRS (St. Jude Medical) a. 2006-‐2007 b. The Methodist Hospital c. Principal Investigator 61. Cryocor-‐ 1CE-‐PAF (Cryotherapy vs. Anti-‐Arrhythmic MEDS for Treatment for Paroxysmal AFIB) a. 2006-‐present b. The Methodist Hospital c. Principal Investigator 62. Connect Study ( Clinical evaluation Of remote Notification to reduce Time to Clinical Decision) Medtronic a. 2007-‐present b. The Methodist Hospital c. Principal Investigator 63. Enable Study Pivotal Clinical Study of the Cardiofocus Endoscopic Ablation System for the Treatment of Symptomatic Atrial Fibrillation a. 2007-‐present
08/04/2010
b. Cardio Focus c. Co-‐Investigator 64. Determine Defibrillators To Reduce Risk by Magnetic Resonance Imaging Evaluation St. Jude Medical a. 2008-‐Present b. The Methodist Hospital c. Investigator 65. Optimum Lead Registry Study a. 2008-‐Present b. St. Jude Medical c. Investigator 66. Game Study a. 2008-‐present b. Medtronic c. Investigator 67. SLS a. 2009-‐Present b. Sponsored by Medtronic c. Investigator 68. Predicts study a. 2009-‐Present b. Sponsored by Medtronic and Lifevest c. Co-‐Investigator 69. Culturing Cardiac Rhythm Devices a. 2009 b. The Methodist Hospital c. Co-‐Investigator 70. Longitudinal Surveillance Registry of the ACUITY Spiral Lead a. 2009-‐ Present b. Sponsored by Boston Scientific c. Co-‐Investigator 71.
1. Full Papers Nasir N Jr, Doyle TK, Wheeler SH, Pacifico A: Usefulness of Holter Monitoring in Predicting Efficacy of Amiodarone Therapy for Sustained Ventricular Tachycardia Associated with Coronary Artery Disease. a. American Journal of Cardiology b. 1994;73:554-‐558 Nasir N Jr, Taylor A, Doyle TK and Pacifico A: Evaluation of Intravenous Lidocaine for the Termination of Sustained Monomorphic Ventricular Tachycardia in Patients with Coronary Artery Disease With or Without Healed Myocardial Infarction. a. American Journal of Cardiology, b. 1994;74:1183-‐1186.
a. American Journal of Cardiology b. 1994;75:470-‐475
Amiodarone: Prediction of Efficacy with Serial Electrophysiologic Studies Yüklə 230,22 Kb. Dostları ilə paylaş:
|